nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—P-Glycoprotein Inhibitors—Cyclosporine—rheumatoid arthritis	0.384	0.521	CiPCiCtD
Ticagrelor—Cytochrome P450 3A4 Inhibitors—Cyclosporine—rheumatoid arthritis	0.353	0.479	CiPCiCtD
Ticagrelor—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0214	0.115	CbGbCtD
Ticagrelor—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0174	0.0934	CbGbCtD
Ticagrelor—ABCB1—Betamethasone—rheumatoid arthritis	0.0139	0.0747	CbGbCtD
Ticagrelor—ABCB1—Prednisolone—rheumatoid arthritis	0.0137	0.0737	CbGbCtD
Ticagrelor—ABCB1—Hydrocortisone—rheumatoid arthritis	0.013	0.0699	CbGbCtD
Ticagrelor—ABCB1—Prednisone—rheumatoid arthritis	0.013	0.0696	CbGbCtD
Ticagrelor—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0128	0.0689	CbGbCtD
Ticagrelor—ABCB1—Cyclosporine—rheumatoid arthritis	0.0123	0.066	CbGbCtD
Ticagrelor—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00971	0.0522	CbGbCtD
Ticagrelor—CYP3A4—Betamethasone—rheumatoid arthritis	0.00833	0.0448	CbGbCtD
Ticagrelor—CYP3A4—Prednisolone—rheumatoid arthritis	0.00822	0.0442	CbGbCtD
Ticagrelor—ABCB1—Dexamethasone—rheumatoid arthritis	0.00809	0.0435	CbGbCtD
Ticagrelor—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00779	0.0419	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—rheumatoid arthritis	0.00776	0.0417	CbGbCtD
Ticagrelor—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00736	0.0396	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—rheumatoid arthritis	0.0065	0.0349	CbGbCtD
Ticagrelor—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00485	0.026	CbGbCtD
Ticagrelor—Angiopathy—Dexamethasone—rheumatoid arthritis	8.81e-05	0.00144	CcSEcCtD
Ticagrelor—Angiopathy—Betamethasone—rheumatoid arthritis	8.81e-05	0.00144	CcSEcCtD
Ticagrelor—Hypertension—Prednisolone—rheumatoid arthritis	8.75e-05	0.00143	CcSEcCtD
Ticagrelor—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	8.7e-05	0.00142	CcSEcCtD
Ticagrelor—Hypersensitivity—Leflunomide—rheumatoid arthritis	8.68e-05	0.00142	CcSEcCtD
Ticagrelor—Bradycardia—Prednisone—rheumatoid arthritis	8.61e-05	0.00141	CcSEcCtD
Ticagrelor—Hypertension—Hydrocortisone—rheumatoid arthritis	8.55e-05	0.0014	CcSEcCtD
Ticagrelor—Diarrhoea—Azathioprine—rheumatoid arthritis	8.53e-05	0.0014	CcSEcCtD
Ticagrelor—Angioedema—Triamcinolone—rheumatoid arthritis	8.52e-05	0.00139	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisone—rheumatoid arthritis	8.5e-05	0.00139	CcSEcCtD
Ticagrelor—Angioedema—Methylprednisolone—rheumatoid arthritis	8.5e-05	0.00139	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—rheumatoid arthritis	8.46e-05	0.00138	CcSEcCtD
Ticagrelor—Asthenia—Leflunomide—rheumatoid arthritis	8.45e-05	0.00138	CcSEcCtD
Ticagrelor—Vertigo—Triamcinolone—rheumatoid arthritis	8.37e-05	0.00137	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	8.37e-05	0.00137	CcSEcCtD
Ticagrelor—Syncope—Triamcinolone—rheumatoid arthritis	8.36e-05	0.00137	CcSEcCtD
Ticagrelor—Vertigo—Methylprednisolone—rheumatoid arthritis	8.36e-05	0.00137	CcSEcCtD
Ticagrelor—Syncope—Methylprednisolone—rheumatoid arthritis	8.34e-05	0.00137	CcSEcCtD
Ticagrelor—Pruritus—Leflunomide—rheumatoid arthritis	8.33e-05	0.00136	CcSEcCtD
Ticagrelor—Connective tissue disorder—Prednisone—rheumatoid arthritis	8.31e-05	0.00136	CcSEcCtD
Ticagrelor—Dizziness—Azathioprine—rheumatoid arthritis	8.25e-05	0.00135	CcSEcCtD
Ticagrelor—Loss of consciousness—Triamcinolone—rheumatoid arthritis	8.19e-05	0.00134	CcSEcCtD
Ticagrelor—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	8.17e-05	0.00134	CcSEcCtD
Ticagrelor—Paraesthesia—Cyclosporine—rheumatoid arthritis	8.16e-05	0.00134	CcSEcCtD
Ticagrelor—Shock—Prednisolone—rheumatoid arthritis	8.14e-05	0.00133	CcSEcCtD
Ticagrelor—Cough—Triamcinolone—rheumatoid arthritis	8.13e-05	0.00133	CcSEcCtD
Ticagrelor—Dyspnoea—Cyclosporine—rheumatoid arthritis	8.1e-05	0.00133	CcSEcCtD
Ticagrelor—Diarrhoea—Leflunomide—rheumatoid arthritis	8.06e-05	0.00132	CcSEcCtD
Ticagrelor—Hypertension—Triamcinolone—rheumatoid arthritis	8.05e-05	0.00132	CcSEcCtD
Ticagrelor—Hypertension—Methylprednisolone—rheumatoid arthritis	8.03e-05	0.00131	CcSEcCtD
Ticagrelor—Dyspepsia—Cyclosporine—rheumatoid arthritis	8e-05	0.00131	CcSEcCtD
Ticagrelor—Shock—Hydrocortisone—rheumatoid arthritis	7.95e-05	0.0013	CcSEcCtD
Ticagrelor—Vomiting—Azathioprine—rheumatoid arthritis	7.93e-05	0.0013	CcSEcCtD
Ticagrelor—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	7.92e-05	0.0013	CcSEcCtD
Ticagrelor—Eye disorder—Prednisone—rheumatoid arthritis	7.91e-05	0.00129	CcSEcCtD
Ticagrelor—Rash—Azathioprine—rheumatoid arthritis	7.86e-05	0.00129	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	7.86e-05	0.00129	CcSEcCtD
Ticagrelor—Dermatitis—Azathioprine—rheumatoid arthritis	7.86e-05	0.00129	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	7.85e-05	0.00128	CcSEcCtD
Ticagrelor—Skin disorder—Hydrocortisone—rheumatoid arthritis	7.85e-05	0.00128	CcSEcCtD
Ticagrelor—Fatigue—Cyclosporine—rheumatoid arthritis	7.84e-05	0.00128	CcSEcCtD
Ticagrelor—Headache—Azathioprine—rheumatoid arthritis	7.81e-05	0.00128	CcSEcCtD
Ticagrelor—Dizziness—Leflunomide—rheumatoid arthritis	7.79e-05	0.00127	CcSEcCtD
Ticagrelor—Constipation—Cyclosporine—rheumatoid arthritis	7.77e-05	0.00127	CcSEcCtD
Ticagrelor—Angioedema—Betamethasone—rheumatoid arthritis	7.73e-05	0.00126	CcSEcCtD
Ticagrelor—Angioedema—Dexamethasone—rheumatoid arthritis	7.73e-05	0.00126	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—rheumatoid arthritis	7.68e-05	0.00126	CcSEcCtD
Ticagrelor—Confusional state—Methylprednisolone—rheumatoid arthritis	7.65e-05	0.00125	CcSEcCtD
Ticagrelor—Immune system disorder—Prednisone—rheumatoid arthritis	7.64e-05	0.00125	CcSEcCtD
Ticagrelor—Vertigo—Betamethasone—rheumatoid arthritis	7.6e-05	0.00124	CcSEcCtD
Ticagrelor—Vertigo—Dexamethasone—rheumatoid arthritis	7.6e-05	0.00124	CcSEcCtD
Ticagrelor—Syncope—Dexamethasone—rheumatoid arthritis	7.58e-05	0.00124	CcSEcCtD
Ticagrelor—Syncope—Betamethasone—rheumatoid arthritis	7.58e-05	0.00124	CcSEcCtD
Ticagrelor—Hypotension—Hydrocortisone—rheumatoid arthritis	7.55e-05	0.00124	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—rheumatoid arthritis	7.51e-05	0.00123	CcSEcCtD
Ticagrelor—Feeling abnormal—Cyclosporine—rheumatoid arthritis	7.49e-05	0.00123	CcSEcCtD
Ticagrelor—Vomiting—Leflunomide—rheumatoid arthritis	7.49e-05	0.00123	CcSEcCtD
Ticagrelor—Shock—Triamcinolone—rheumatoid arthritis	7.48e-05	0.00122	CcSEcCtD
Ticagrelor—Shock—Methylprednisolone—rheumatoid arthritis	7.47e-05	0.00122	CcSEcCtD
Ticagrelor—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	7.44e-05	0.00122	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	7.43e-05	0.00122	CcSEcCtD
Ticagrelor—Loss of consciousness—Dexamethasone—rheumatoid arthritis	7.43e-05	0.00122	CcSEcCtD
Ticagrelor—Loss of consciousness—Betamethasone—rheumatoid arthritis	7.43e-05	0.00122	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—rheumatoid arthritis	7.43e-05	0.00122	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisolone—rheumatoid arthritis	7.43e-05	0.00122	CcSEcCtD
Ticagrelor—Rash—Leflunomide—rheumatoid arthritis	7.43e-05	0.00122	CcSEcCtD
Ticagrelor—Dermatitis—Leflunomide—rheumatoid arthritis	7.42e-05	0.00121	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—rheumatoid arthritis	7.41e-05	0.00121	CcSEcCtD
Ticagrelor—Nausea—Azathioprine—rheumatoid arthritis	7.41e-05	0.00121	CcSEcCtD
Ticagrelor—Headache—Leflunomide—rheumatoid arthritis	7.38e-05	0.00121	CcSEcCtD
Ticagrelor—Skin disorder—Methylprednisolone—rheumatoid arthritis	7.37e-05	0.00121	CcSEcCtD
Ticagrelor—Malnutrition—Prednisone—rheumatoid arthritis	7.37e-05	0.00121	CcSEcCtD
Ticagrelor—Hypertension—Betamethasone—rheumatoid arthritis	7.3e-05	0.0012	CcSEcCtD
Ticagrelor—Hypertension—Dexamethasone—rheumatoid arthritis	7.3e-05	0.0012	CcSEcCtD
Ticagrelor—Paraesthesia—Hydrocortisone—rheumatoid arthritis	7.25e-05	0.00119	CcSEcCtD
Ticagrelor—Abdominal pain—Cyclosporine—rheumatoid arthritis	7.19e-05	0.00118	CcSEcCtD
Ticagrelor—Body temperature increased—Cyclosporine—rheumatoid arthritis	7.19e-05	0.00118	CcSEcCtD
Ticagrelor—Dyspepsia—Hydrocortisone—rheumatoid arthritis	7.11e-05	0.00116	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—rheumatoid arthritis	7.11e-05	0.00116	CcSEcCtD
Ticagrelor—Hypotension—Methylprednisolone—rheumatoid arthritis	7.09e-05	0.00116	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—rheumatoid arthritis	7.07e-05	0.00116	CcSEcCtD
Ticagrelor—Nausea—Leflunomide—rheumatoid arthritis	7e-05	0.00115	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—rheumatoid arthritis	6.98e-05	0.00114	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	6.97e-05	0.00114	CcSEcCtD
Ticagrelor—Fatigue—Hydrocortisone—rheumatoid arthritis	6.97e-05	0.00114	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—rheumatoid arthritis	6.93e-05	0.00113	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CCL3—rheumatoid arthritis	6.86e-05	0.00458	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—C5—rheumatoid arthritis	6.86e-05	0.00458	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IL2RA—rheumatoid arthritis	6.84e-05	0.00457	CbGpPWpGaD
Ticagrelor—Paraesthesia—Triamcinolone—rheumatoid arthritis	6.83e-05	0.00112	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisolone—rheumatoid arthritis	6.82e-05	0.00112	CcSEcCtD
Ticagrelor—Paraesthesia—Methylprednisolone—rheumatoid arthritis	6.82e-05	0.00112	CcSEcCtD
Ticagrelor—Shock—Dexamethasone—rheumatoid arthritis	6.79e-05	0.00111	CcSEcCtD
Ticagrelor—Shock—Betamethasone—rheumatoid arthritis	6.79e-05	0.00111	CcSEcCtD
Ticagrelor—Dyspnoea—Triamcinolone—rheumatoid arthritis	6.78e-05	0.00111	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—rheumatoid arthritis	6.77e-05	0.00452	CbGpPWpGaD
Ticagrelor—Nervous system disorder—Dexamethasone—rheumatoid arthritis	6.77e-05	0.00111	CcSEcCtD
Ticagrelor—Nervous system disorder—Betamethasone—rheumatoid arthritis	6.77e-05	0.00111	CcSEcCtD
Ticagrelor—Angioedema—Prednisone—rheumatoid arthritis	6.73e-05	0.0011	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—SAA1—rheumatoid arthritis	6.71e-05	0.00448	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ITGAM—rheumatoid arthritis	6.71e-05	0.00448	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Cyclosporine—rheumatoid arthritis	6.7e-05	0.0011	CcSEcCtD
Ticagrelor—Dyspepsia—Triamcinolone—rheumatoid arthritis	6.7e-05	0.0011	CcSEcCtD
Ticagrelor—Dyspepsia—Methylprednisolone—rheumatoid arthritis	6.68e-05	0.00109	CcSEcCtD
Ticagrelor—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	6.66e-05	0.00109	CcSEcCtD
Ticagrelor—Vertigo—Prednisone—rheumatoid arthritis	6.62e-05	0.00108	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—rheumatoid arthritis	6.61e-05	0.00108	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—CCR5—rheumatoid arthritis	6.61e-05	0.00441	CbGpPWpGaD
Ticagrelor—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	6.61e-05	0.00108	CcSEcCtD
Ticagrelor—Syncope—Prednisone—rheumatoid arthritis	6.61e-05	0.00108	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—rheumatoid arthritis	6.56e-05	0.00107	CcSEcCtD
Ticagrelor—Fatigue—Triamcinolone—rheumatoid arthritis	6.56e-05	0.00107	CcSEcCtD
Ticagrelor—Fatigue—Methylprednisolone—rheumatoid arthritis	6.54e-05	0.00107	CcSEcCtD
Ticagrelor—Asthenia—Cyclosporine—rheumatoid arthritis	6.52e-05	0.00107	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisone—rheumatoid arthritis	6.47e-05	0.00106	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—C3—rheumatoid arthritis	6.46e-05	0.00431	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—ENO1—rheumatoid arthritis	6.46e-05	0.00431	CbGpPWpGaD
Ticagrelor—Hypotension—Betamethasone—rheumatoid arthritis	6.45e-05	0.00106	CcSEcCtD
Ticagrelor—Hypotension—Dexamethasone—rheumatoid arthritis	6.45e-05	0.00106	CcSEcCtD
Ticagrelor—Pruritus—Cyclosporine—rheumatoid arthritis	6.43e-05	0.00105	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—rheumatoid arthritis	6.42e-05	0.00105	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—rheumatoid arthritis	6.39e-05	0.00105	CcSEcCtD
Ticagrelor—Body temperature increased—Hydrocortisone—rheumatoid arthritis	6.39e-05	0.00105	CcSEcCtD
Ticagrelor—Abdominal pain—Hydrocortisone—rheumatoid arthritis	6.39e-05	0.00105	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—rheumatoid arthritis	6.37e-05	0.00104	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—SH2B3—rheumatoid arthritis	6.36e-05	0.00425	CbGpPWpGaD
Ticagrelor—Hypertension—Prednisone—rheumatoid arthritis	6.36e-05	0.00104	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—PDE2A—rheumatoid arthritis	6.36e-05	0.00425	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Triamcinolone—rheumatoid arthritis	6.27e-05	0.00103	CcSEcCtD
Ticagrelor—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	6.25e-05	0.00102	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	6.23e-05	0.00102	CcSEcCtD
Ticagrelor—Diarrhoea—Cyclosporine—rheumatoid arthritis	6.22e-05	0.00102	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	6.21e-05	0.00102	CcSEcCtD
Ticagrelor—Paraesthesia—Betamethasone—rheumatoid arthritis	6.2e-05	0.00101	CcSEcCtD
Ticagrelor—Paraesthesia—Dexamethasone—rheumatoid arthritis	6.2e-05	0.00101	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—rheumatoid arthritis	6.19e-05	0.00101	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—rheumatoid arthritis	6.16e-05	0.00101	CcSEcCtD
Ticagrelor—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—rheumatoid arthritis	6.13e-05	0.00409	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisolone—rheumatoid arthritis	6.09e-05	0.000998	CcSEcCtD
Ticagrelor—Dyspepsia—Betamethasone—rheumatoid arthritis	6.08e-05	0.000994	CcSEcCtD
Ticagrelor—Dyspepsia—Dexamethasone—rheumatoid arthritis	6.08e-05	0.000994	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—GZMB—rheumatoid arthritis	6.08e-05	0.00406	CbGpPWpGaD
Ticagrelor—Body temperature increased—Triamcinolone—rheumatoid arthritis	6.01e-05	0.000984	CcSEcCtD
Ticagrelor—Dizziness—Cyclosporine—rheumatoid arthritis	6.01e-05	0.000984	CcSEcCtD
Ticagrelor—Abdominal pain—Methylprednisolone—rheumatoid arthritis	6e-05	0.000982	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	5.96e-05	0.000975	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	5.96e-05	0.000975	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—FN1—rheumatoid arthritis	5.95e-05	0.00398	CbGpPWpGaD
Ticagrelor—Back pain—Methotrexate—rheumatoid arthritis	5.95e-05	0.000975	CcSEcCtD
Ticagrelor—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	5.95e-05	0.000974	CcSEcCtD
Ticagrelor—Fatigue—Betamethasone—rheumatoid arthritis	5.95e-05	0.000974	CcSEcCtD
Ticagrelor—Fatigue—Dexamethasone—rheumatoid arthritis	5.95e-05	0.000974	CcSEcCtD
Ticagrelor—Shock—Prednisone—rheumatoid arthritis	5.91e-05	0.000968	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—rheumatoid arthritis	5.89e-05	0.000965	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—rheumatoid arthritis	5.84e-05	0.000956	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—BDKRB2—rheumatoid arthritis	5.84e-05	0.0039	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL12—rheumatoid arthritis	5.84e-05	0.0039	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—rheumatoid arthritis	5.83e-05	0.00389	CbGpPWpGaD
Ticagrelor—Asthenia—Hydrocortisone—rheumatoid arthritis	5.8e-05	0.000949	CcSEcCtD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—CXCL12—rheumatoid arthritis	5.79e-05	0.00387	CbGpPWpGaD
Ticagrelor—Vomiting—Cyclosporine—rheumatoid arthritis	5.78e-05	0.000946	CcSEcCtD
Ticagrelor—Rash—Cyclosporine—rheumatoid arthritis	5.73e-05	0.000938	CcSEcCtD
Ticagrelor—Dermatitis—Cyclosporine—rheumatoid arthritis	5.73e-05	0.000937	CcSEcCtD
Ticagrelor—Pruritus—Hydrocortisone—rheumatoid arthritis	5.72e-05	0.000936	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—GATA3—rheumatoid arthritis	5.71e-05	0.00381	CbGpPWpGaD
Ticagrelor—Headache—Cyclosporine—rheumatoid arthritis	5.69e-05	0.000932	CcSEcCtD
Ticagrelor—Feeling abnormal—Betamethasone—rheumatoid arthritis	5.69e-05	0.000931	CcSEcCtD
Ticagrelor—Feeling abnormal—Dexamethasone—rheumatoid arthritis	5.69e-05	0.000931	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	5.64e-05	0.000924	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	5.64e-05	0.000924	CcSEcCtD
Ticagrelor—Hypersensitivity—Triamcinolone—rheumatoid arthritis	5.6e-05	0.000917	CcSEcCtD
Ticagrelor—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	5.59e-05	0.000915	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL17A—rheumatoid arthritis	5.59e-05	0.00373	CbGpPWpGaD
Ticagrelor—Vertigo—Methotrexate—rheumatoid arthritis	5.53e-05	0.000905	CcSEcCtD
Ticagrelor—Diarrhoea—Hydrocortisone—rheumatoid arthritis	5.53e-05	0.000905	CcSEcCtD
Ticagrelor—Dizziness—Prednisolone—rheumatoid arthritis	5.47e-05	0.000895	CcSEcCtD
Ticagrelor—Asthenia—Triamcinolone—rheumatoid arthritis	5.46e-05	0.000893	CcSEcCtD
Ticagrelor—Abdominal pain—Betamethasone—rheumatoid arthritis	5.46e-05	0.000893	CcSEcCtD
Ticagrelor—Abdominal pain—Dexamethasone—rheumatoid arthritis	5.46e-05	0.000893	CcSEcCtD
Ticagrelor—Body temperature increased—Dexamethasone—rheumatoid arthritis	5.46e-05	0.000893	CcSEcCtD
Ticagrelor—Body temperature increased—Betamethasone—rheumatoid arthritis	5.46e-05	0.000893	CcSEcCtD
Ticagrelor—Asthenia—Methylprednisolone—rheumatoid arthritis	5.45e-05	0.000891	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL13—rheumatoid arthritis	5.44e-05	0.00364	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD28—rheumatoid arthritis	5.43e-05	0.00363	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TIMP1—rheumatoid arthritis	5.41e-05	0.00361	CbGpPWpGaD
Ticagrelor—Nausea—Cyclosporine—rheumatoid arthritis	5.4e-05	0.000884	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisone—rheumatoid arthritis	5.4e-05	0.000883	CcSEcCtD
Ticagrelor—Pruritus—Triamcinolone—rheumatoid arthritis	5.38e-05	0.000881	CcSEcCtD
Ticagrelor—Cough—Methotrexate—rheumatoid arthritis	5.37e-05	0.000879	CcSEcCtD
Ticagrelor—Pruritus—Methylprednisolone—rheumatoid arthritis	5.37e-05	0.000879	CcSEcCtD
Ticagrelor—Dizziness—Hydrocortisone—rheumatoid arthritis	5.34e-05	0.000874	CcSEcCtD
Ticagrelor—Dyspepsia—Prednisone—rheumatoid arthritis	5.29e-05	0.000866	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—rheumatoid arthritis	5.25e-05	0.00351	CbGpPWpGaD
Ticagrelor—Chest pain—Methotrexate—rheumatoid arthritis	5.24e-05	0.000858	CcSEcCtD
Ticagrelor—Rash—Prednisolone—rheumatoid arthritis	5.22e-05	0.000854	CcSEcCtD
Ticagrelor—Dermatitis—Prednisolone—rheumatoid arthritis	5.21e-05	0.000853	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	5.2e-05	0.000852	CcSEcCtD
Ticagrelor—Diarrhoea—Methylprednisolone—rheumatoid arthritis	5.19e-05	0.00085	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—rheumatoid arthritis	5.18e-05	0.000848	CcSEcCtD
Ticagrelor—Headache—Prednisolone—rheumatoid arthritis	5.18e-05	0.000848	CcSEcCtD
Ticagrelor—P2RY12—G alpha (i) signalling events—POMC—rheumatoid arthritis	5.16e-05	0.00345	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL10—rheumatoid arthritis	5.16e-05	0.00345	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DPB1—rheumatoid arthritis	5.16e-05	0.00344	CbGpPWpGaD
Ticagrelor—Constipation—Prednisone—rheumatoid arthritis	5.14e-05	0.000841	CcSEcCtD
Ticagrelor—Vomiting—Hydrocortisone—rheumatoid arthritis	5.14e-05	0.000841	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—C3—rheumatoid arthritis	5.13e-05	0.00343	CbGpPWpGaD
Ticagrelor—Rash—Hydrocortisone—rheumatoid arthritis	5.09e-05	0.000834	CcSEcCtD
Ticagrelor—Dermatitis—Hydrocortisone—rheumatoid arthritis	5.09e-05	0.000833	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—rheumatoid arthritis	5.07e-05	0.000829	CcSEcCtD
Ticagrelor—Headache—Hydrocortisone—rheumatoid arthritis	5.06e-05	0.000828	CcSEcCtD
Ticagrelor—Dizziness—Triamcinolone—rheumatoid arthritis	5.03e-05	0.000823	CcSEcCtD
Ticagrelor—Dizziness—Methylprednisolone—rheumatoid arthritis	5.02e-05	0.000822	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CXCL12—rheumatoid arthritis	5.02e-05	0.00335	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD40—rheumatoid arthritis	4.96e-05	0.00331	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL6—rheumatoid arthritis	4.96e-05	0.00331	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Prednisone—rheumatoid arthritis	4.95e-05	0.000811	CcSEcCtD
Ticagrelor—Asthenia—Betamethasone—rheumatoid arthritis	4.95e-05	0.000811	CcSEcCtD
Ticagrelor—Asthenia—Dexamethasone—rheumatoid arthritis	4.95e-05	0.000811	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—ALB—rheumatoid arthritis	4.95e-05	0.0033	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL13—rheumatoid arthritis	4.94e-05	0.0033	CbGpPWpGaD
Ticagrelor—Nervous system disorder—Methotrexate—rheumatoid arthritis	4.93e-05	0.000806	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Prednisone—rheumatoid arthritis	4.92e-05	0.000805	CcSEcCtD
Ticagrelor—Nausea—Prednisolone—rheumatoid arthritis	4.91e-05	0.000804	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—CTLA4—rheumatoid arthritis	4.89e-05	0.00326	CbGpPWpGaD
Ticagrelor—Pruritus—Betamethasone—rheumatoid arthritis	4.88e-05	0.000799	CcSEcCtD
Ticagrelor—Pruritus—Dexamethasone—rheumatoid arthritis	4.88e-05	0.000799	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—rheumatoid arthritis	4.88e-05	0.000799	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—RASGRP1—rheumatoid arthritis	4.87e-05	0.00325	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—SYK—rheumatoid arthritis	4.85e-05	0.00324	CbGpPWpGaD
Ticagrelor—Vomiting—Triamcinolone—rheumatoid arthritis	4.84e-05	0.000792	CcSEcCtD
Ticagrelor—Vomiting—Methylprednisolone—rheumatoid arthritis	4.83e-05	0.00079	CcSEcCtD
Ticagrelor—Nausea—Hydrocortisone—rheumatoid arthritis	4.8e-05	0.000785	CcSEcCtD
Ticagrelor—Rash—Triamcinolone—rheumatoid arthritis	4.8e-05	0.000785	CcSEcCtD
Ticagrelor—Dermatitis—Triamcinolone—rheumatoid arthritis	4.79e-05	0.000784	CcSEcCtD
Ticagrelor—Rash—Methylprednisolone—rheumatoid arthritis	4.79e-05	0.000783	CcSEcCtD
Ticagrelor—Dermatitis—Methylprednisolone—rheumatoid arthritis	4.78e-05	0.000783	CcSEcCtD
Ticagrelor—Headache—Triamcinolone—rheumatoid arthritis	4.77e-05	0.00078	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—PRKCQ—rheumatoid arthritis	4.76e-05	0.00318	CbGpPWpGaD
Ticagrelor—Headache—Methylprednisolone—rheumatoid arthritis	4.76e-05	0.000778	CcSEcCtD
Ticagrelor—Body temperature increased—Prednisone—rheumatoid arthritis	4.75e-05	0.000778	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—rheumatoid arthritis	4.75e-05	0.000778	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—CCL21—rheumatoid arthritis	4.73e-05	0.00316	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SYVN1—rheumatoid arthritis	4.73e-05	0.00316	CbGpPWpGaD
Ticagrelor—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—rheumatoid arthritis	4.73e-05	0.00316	CbGpPWpGaD
Ticagrelor—Diarrhoea—Betamethasone—rheumatoid arthritis	4.72e-05	0.000773	CcSEcCtD
Ticagrelor—Diarrhoea—Dexamethasone—rheumatoid arthritis	4.72e-05	0.000773	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—rheumatoid arthritis	4.69e-05	0.000768	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2RB—rheumatoid arthritis	4.67e-05	0.00312	CbGpPWpGaD
Ticagrelor—Dizziness—Dexamethasone—rheumatoid arthritis	4.56e-05	0.000747	CcSEcCtD
Ticagrelor—Dizziness—Betamethasone—rheumatoid arthritis	4.56e-05	0.000747	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—TAGAP—rheumatoid arthritis	4.53e-05	0.00303	CbGpPWpGaD
Ticagrelor—Nausea—Triamcinolone—rheumatoid arthritis	4.52e-05	0.00074	CcSEcCtD
Ticagrelor—P2RY12—GPCR downstream signaling—C5—rheumatoid arthritis	4.51e-05	0.00301	CbGpPWpGaD
Ticagrelor—Paraesthesia—Methotrexate—rheumatoid arthritis	4.51e-05	0.000738	CcSEcCtD
Ticagrelor—Nausea—Methylprednisolone—rheumatoid arthritis	4.51e-05	0.000738	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—STAT1—rheumatoid arthritis	4.5e-05	0.003	CbGpPWpGaD
Ticagrelor—Dyspnoea—Methotrexate—rheumatoid arthritis	4.48e-05	0.000733	CcSEcCtD
Ticagrelor—P2RY12—GPCR ligand binding—CCL5—rheumatoid arthritis	4.44e-05	0.00297	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Prednisone—rheumatoid arthritis	4.43e-05	0.000725	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—rheumatoid arthritis	4.42e-05	0.000724	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—CX3CR1—rheumatoid arthritis	4.41e-05	0.00294	CbGpPWpGaD
Ticagrelor—Vomiting—Betamethasone—rheumatoid arthritis	4.39e-05	0.000718	CcSEcCtD
Ticagrelor—Vomiting—Dexamethasone—rheumatoid arthritis	4.39e-05	0.000718	CcSEcCtD
Ticagrelor—Rash—Betamethasone—rheumatoid arthritis	4.35e-05	0.000712	CcSEcCtD
Ticagrelor—Rash—Dexamethasone—rheumatoid arthritis	4.35e-05	0.000712	CcSEcCtD
Ticagrelor—Dermatitis—Betamethasone—rheumatoid arthritis	4.35e-05	0.000712	CcSEcCtD
Ticagrelor—Dermatitis—Dexamethasone—rheumatoid arthritis	4.35e-05	0.000712	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	4.34e-05	0.00071	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—rheumatoid arthritis	4.33e-05	0.000709	CcSEcCtD
Ticagrelor—Headache—Dexamethasone—rheumatoid arthritis	4.32e-05	0.000708	CcSEcCtD
Ticagrelor—Headache—Betamethasone—rheumatoid arthritis	4.32e-05	0.000708	CcSEcCtD
Ticagrelor—Asthenia—Prednisone—rheumatoid arthritis	4.31e-05	0.000706	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DQA1—rheumatoid arthritis	4.3e-05	0.00287	CbGpPWpGaD
Ticagrelor—Pruritus—Prednisone—rheumatoid arthritis	4.25e-05	0.000696	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—IL2RB—rheumatoid arthritis	4.24e-05	0.00283	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR6—rheumatoid arthritis	4.24e-05	0.00283	CbGpPWpGaD
Ticagrelor—Feeling abnormal—Methotrexate—rheumatoid arthritis	4.14e-05	0.000678	CcSEcCtD
Ticagrelor—Diarrhoea—Prednisone—rheumatoid arthritis	4.11e-05	0.000673	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	4.11e-05	0.000672	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—POMC—rheumatoid arthritis	4.11e-05	0.00274	CbGpPWpGaD
Ticagrelor—Nausea—Dexamethasone—rheumatoid arthritis	4.1e-05	0.000671	CcSEcCtD
Ticagrelor—Nausea—Betamethasone—rheumatoid arthritis	4.1e-05	0.000671	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—C5—rheumatoid arthritis	4.1e-05	0.00274	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—PTK2—rheumatoid arthritis	4.05e-05	0.0027	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DQB1—rheumatoid arthritis	4.02e-05	0.00269	CbGpPWpGaD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL2—rheumatoid arthritis	4.02e-05	0.00268	CbGpPWpGaD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—IL2—rheumatoid arthritis	4.01e-05	0.00268	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCR5—rheumatoid arthritis	4e-05	0.00267	CbGpPWpGaD
Ticagrelor—P2RY12—G alpha (i) signalling events—CXCL8—rheumatoid arthritis	3.99e-05	0.00267	CbGpPWpGaD
Ticagrelor—Dizziness—Prednisone—rheumatoid arthritis	3.97e-05	0.000651	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—rheumatoid arthritis	3.97e-05	0.00065	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—rheumatoid arthritis	3.97e-05	0.00065	CcSEcCtD
Ticagrelor—P2RY12—Hemostasis—CSF2—rheumatoid arthritis	3.91e-05	0.00261	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—C3—rheumatoid arthritis	3.91e-05	0.00261	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL2—rheumatoid arthritis	3.88e-05	0.00259	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR6—rheumatoid arthritis	3.85e-05	0.00257	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1A—rheumatoid arthritis	3.82e-05	0.00255	CbGpPWpGaD
Ticagrelor—Vomiting—Prednisone—rheumatoid arthritis	3.82e-05	0.000626	CcSEcCtD
Ticagrelor—CYP3A4—Tryptophan metabolism—CAT—rheumatoid arthritis	3.82e-05	0.00255	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD40LG—rheumatoid arthritis	3.8e-05	0.00254	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL10—rheumatoid arthritis	3.8e-05	0.00254	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—SAA1—rheumatoid arthritis	3.79e-05	0.00253	CbGpPWpGaD
Ticagrelor—Rash—Prednisone—rheumatoid arthritis	3.79e-05	0.00062	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—rheumatoid arthritis	3.79e-05	0.00062	CcSEcCtD
Ticagrelor—Headache—Prednisone—rheumatoid arthritis	3.77e-05	0.000616	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—PDE2A—rheumatoid arthritis	3.76e-05	0.00251	CbGpPWpGaD
Ticagrelor—Hypersensitivity—Methotrexate—rheumatoid arthritis	3.7e-05	0.000606	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—IL4—rheumatoid arthritis	3.7e-05	0.00247	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-B—rheumatoid arthritis	3.62e-05	0.00241	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—LEP—rheumatoid arthritis	3.61e-05	0.00241	CbGpPWpGaD
Ticagrelor—Asthenia—Methotrexate—rheumatoid arthritis	3.6e-05	0.00059	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—PLB1—rheumatoid arthritis	3.58e-05	0.00239	CbGpPWpGaD
Ticagrelor—Nausea—Prednisone—rheumatoid arthritis	3.57e-05	0.000584	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—rheumatoid arthritis	3.55e-05	0.000582	CcSEcCtD
Ticagrelor—ABCB1—Allograft Rejection—FASLG—rheumatoid arthritis	3.53e-05	0.00236	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2RA—rheumatoid arthritis	3.53e-05	0.00235	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL2—rheumatoid arthritis	3.52e-05	0.00235	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL3—rheumatoid arthritis	3.52e-05	0.00235	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—SAA1—rheumatoid arthritis	3.45e-05	0.0023	CbGpPWpGaD
Ticagrelor—Diarrhoea—Methotrexate—rheumatoid arthritis	3.44e-05	0.000563	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—VEGFA—rheumatoid arthritis	3.41e-05	0.00228	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—FAS—rheumatoid arthritis	3.41e-05	0.00228	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL2RA—rheumatoid arthritis	3.39e-05	0.00226	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—NOS2—rheumatoid arthritis	3.36e-05	0.00225	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—MMP1—rheumatoid arthritis	3.36e-05	0.00225	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—C3—rheumatoid arthritis	3.36e-05	0.00224	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-A—rheumatoid arthritis	3.35e-05	0.00224	CbGpPWpGaD
Ticagrelor—Dizziness—Methotrexate—rheumatoid arthritis	3.32e-05	0.000544	CcSEcCtD
Ticagrelor—P2RY12—Signaling Pathways—RBPJ—rheumatoid arthritis	3.31e-05	0.00221	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—BDKRB2—rheumatoid arthritis	3.3e-05	0.0022	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL12—rheumatoid arthritis	3.3e-05	0.0022	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—ADRBK1—rheumatoid arthritis	3.26e-05	0.00218	CbGpPWpGaD
Ticagrelor—Vomiting—Methotrexate—rheumatoid arthritis	3.19e-05	0.000523	CcSEcCtD
Ticagrelor—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—rheumatoid arthritis	3.18e-05	0.00212	CbGpPWpGaD
Ticagrelor—Rash—Methotrexate—rheumatoid arthritis	3.17e-05	0.000518	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—rheumatoid arthritis	3.16e-05	0.000518	CcSEcCtD
Ticagrelor—Headache—Methotrexate—rheumatoid arthritis	3.15e-05	0.000515	CcSEcCtD
Ticagrelor—P2RY12—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	3.13e-05	0.00209	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—POMC—rheumatoid arthritis	3.13e-05	0.00209	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	3.09e-05	0.00206	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—RASGRP1—rheumatoid arthritis	3.08e-05	0.00205	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—FN1—rheumatoid arthritis	3.07e-05	0.00205	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	3.06e-05	0.00204	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CCL2—rheumatoid arthritis	3.06e-05	0.00204	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS2—rheumatoid arthritis	3.03e-05	0.00203	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—PRKCQ—rheumatoid arthritis	3.01e-05	0.00201	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—BDKRB2—rheumatoid arthritis	3e-05	0.002	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL12—rheumatoid arthritis	3e-05	0.002	CbGpPWpGaD
Ticagrelor—Nausea—Methotrexate—rheumatoid arthritis	2.98e-05	0.000488	CcSEcCtD
Ticagrelor—P2RY12—Signaling by GPCR—ADRBK1—rheumatoid arthritis	2.96e-05	0.00198	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL13—rheumatoid arthritis	2.92e-05	0.00195	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL10—rheumatoid arthritis	2.92e-05	0.00195	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CD80—rheumatoid arthritis	2.83e-05	0.00189	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—RASGRP1—rheumatoid arthritis	2.79e-05	0.00187	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—PRKCQ—rheumatoid arthritis	2.73e-05	0.00183	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL10—rheumatoid arthritis	2.65e-05	0.00177	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TLE3—rheumatoid arthritis	2.63e-05	0.00176	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IRAK1—rheumatoid arthritis	2.63e-05	0.00176	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CX3CR1—rheumatoid arthritis	2.6e-05	0.00174	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—ALB—rheumatoid arthritis	2.55e-05	0.0017	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCL5—rheumatoid arthritis	2.51e-05	0.00168	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2RB—rheumatoid arthritis	2.51e-05	0.00167	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CSF2—rheumatoid arthritis	2.47e-05	0.00165	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	2.45e-05	0.00163	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—NOS3—rheumatoid arthritis	2.44e-05	0.00163	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—C5—rheumatoid arthritis	2.42e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR ligand binding—CXCL8—rheumatoid arthritis	2.42e-05	0.00162	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—MMP3—rheumatoid arthritis	2.41e-05	0.00161	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFATC1—rheumatoid arthritis	2.38e-05	0.00159	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL5—rheumatoid arthritis	2.28e-05	0.00152	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR6—rheumatoid arthritis	2.28e-05	0.00152	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CCR5—rheumatoid arthritis	2.26e-05	0.00151	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CSF2—rheumatoid arthritis	2.24e-05	0.0015	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IFNG—rheumatoid arthritis	2.23e-05	0.00149	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2RA—rheumatoid arthritis	2.23e-05	0.00149	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	2.22e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NCF2—rheumatoid arthritis	2.21e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—C3—rheumatoid arthritis	2.21e-05	0.00148	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SH2B3—rheumatoid arthritis	2.16e-05	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TRAF6—rheumatoid arthritis	2.16e-05	0.00144	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—GZMB—rheumatoid arthritis	2.14e-05	0.00143	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	2.14e-05	0.00143	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL2—rheumatoid arthritis	2.08e-05	0.00139	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL3—rheumatoid arthritis	2.08e-05	0.00139	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—CXCL8—rheumatoid arthritis	2.08e-05	0.00139	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—IL2—rheumatoid arthritis	2.07e-05	0.00138	CbGpPWpGaD
Ticagrelor—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	2.06e-05	0.00138	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCR5—rheumatoid arthritis	2.05e-05	0.00137	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SAA1—rheumatoid arthritis	2.04e-05	0.00136	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2RA—rheumatoid arthritis	2.02e-05	0.00135	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—C3—rheumatoid arthritis	2.01e-05	0.00134	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL1B—rheumatoid arthritis	1.99e-05	0.00133	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NCF1—rheumatoid arthritis	1.99e-05	0.00133	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—IL2—rheumatoid arthritis	1.99e-05	0.00133	CbGpPWpGaD
Ticagrelor—ABCB1—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	1.95e-05	0.0013	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD28—rheumatoid arthritis	1.92e-05	0.00128	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.8e-05	0.00121	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL12—rheumatoid arthritis	1.77e-05	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.77e-05	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—POMC—rheumatoid arthritis	1.77e-05	0.00118	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—VEGFA—rheumatoid arthritis	1.76e-05	0.00117	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6ST—rheumatoid arthritis	1.75e-05	0.00117	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.75e-05	0.00117	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.74e-05	0.00117	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	1.74e-05	0.00116	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—FADS2—rheumatoid arthritis	1.7e-05	0.00114	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—VEGFA—rheumatoid arthritis	1.69e-05	0.00113	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	1.68e-05	0.00112	CbGpPWpGaD
Ticagrelor—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.67e-05	0.00112	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.65e-05	0.0011	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SYK—rheumatoid arthritis	1.65e-05	0.0011	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.61e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TGFB1—rheumatoid arthritis	1.61e-05	0.00108	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—POMC—rheumatoid arthritis	1.6e-05	0.00107	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—STAT1—rheumatoid arthritis	1.59e-05	0.00106	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CCL2—rheumatoid arthritis	1.57e-05	0.00105	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6R—rheumatoid arthritis	1.57e-05	0.00105	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL10—rheumatoid arthritis	1.56e-05	0.00104	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TGFB1—rheumatoid arthritis	1.55e-05	0.00103	CbGpPWpGaD
Ticagrelor—ABCB1—Allograft Rejection—TNF—rheumatoid arthritis	1.45e-05	0.000966	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP3—rheumatoid arthritis	1.43e-05	0.000953	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—TYK2—rheumatoid arthritis	1.43e-05	0.000952	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—PTK2—rheumatoid arthritis	1.37e-05	0.000917	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.37e-05	0.000913	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL5—rheumatoid arthritis	1.35e-05	0.000899	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.33e-05	0.00089	CbGpPWpGaD
Ticagrelor—P2RY12—Hemostasis—TP53—rheumatoid arthritis	1.33e-05	0.000886	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CSF2—rheumatoid arthritis	1.33e-05	0.000886	CbGpPWpGaD
Ticagrelor—P2RY12—GPCR downstream signaling—IL2—rheumatoid arthritis	1.31e-05	0.000872	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—SPP1—rheumatoid arthritis	1.25e-05	0.000833	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.24e-05	0.000829	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCR5—rheumatoid arthritis	1.21e-05	0.00081	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2RA—rheumatoid arthritis	1.2e-05	0.000798	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL2—rheumatoid arthritis	1.19e-05	0.000792	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—C3—rheumatoid arthritis	1.19e-05	0.000792	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLD4—rheumatoid arthritis	1.13e-05	0.000758	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—LEP—rheumatoid arthritis	1.1e-05	0.000737	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACAN—rheumatoid arthritis	1.1e-05	0.000732	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	1.06e-05	0.000706	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	1.05e-05	0.0007	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—FN1—rheumatoid arthritis	1.04e-05	0.000695	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6ST—rheumatoid arthritis	1.04e-05	0.000692	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	1.03e-05	0.000688	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—GC—rheumatoid arthritis	1e-05	0.000669	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGES—rheumatoid arthritis	1e-05	0.000669	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CD80—rheumatoid arthritis	9.98e-06	0.000666	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—POMC—rheumatoid arthritis	9.48e-06	0.000633	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PLB1—rheumatoid arthritis	9.32e-06	0.000622	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CCL2—rheumatoid arthritis	9.27e-06	0.000619	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6R—rheumatoid arthritis	9.25e-06	0.000617	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	9.18e-06	0.000613	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	9.02e-06	0.000602	CbGpPWpGaD
Ticagrelor—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	8.88e-06	0.000593	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TYK2—rheumatoid arthritis	8.42e-06	0.000562	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	8.33e-06	0.000556	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NOS3—rheumatoid arthritis	8.27e-06	0.000552	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MED1—rheumatoid arthritis	8.17e-06	0.000546	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	7.64e-06	0.000511	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ACP5—rheumatoid arthritis	7.6e-06	0.000507	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	7.6e-06	0.000507	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—CXCL8—rheumatoid arthritis	7.33e-06	0.00049	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	7.14e-06	0.000477	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL2—rheumatoid arthritis	7.01e-06	0.000468	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	6.99e-06	0.000467	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling by GPCR—IL6—rheumatoid arthritis	6.97e-06	0.000466	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—BGN—rheumatoid arthritis	6.84e-06	0.000457	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	6.75e-06	0.000451	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MMP9—rheumatoid arthritis	6.63e-06	0.000443	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—NFKB1—rheumatoid arthritis	6.56e-06	0.000438	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—MAPK8—rheumatoid arthritis	6.45e-06	0.000431	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	6.35e-06	0.000424	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	6.29e-06	0.00042	CbGpPWpGaD
Ticagrelor—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	6.29e-06	0.00042	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—GC—rheumatoid arthritis	6.18e-06	0.000412	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	6.18e-06	0.000412	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—VEGFA—rheumatoid arthritis	5.96e-06	0.000398	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	5.74e-06	0.000383	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TGFB1—rheumatoid arthritis	5.47e-06	0.000365	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ENO1—rheumatoid arthritis	5.13e-06	0.000343	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MED1—rheumatoid arthritis	5.03e-06	0.000336	CbGpPWpGaD
Ticagrelor—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	4.8e-06	0.00032	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.68e-06	0.000313	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.68e-06	0.000313	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—TP53—rheumatoid arthritis	4.5e-06	0.000301	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—BGN—rheumatoid arthritis	4.21e-06	0.000281	CbGpPWpGaD
Ticagrelor—P2RY12—Signaling Pathways—IL6—rheumatoid arthritis	4.12e-06	0.000275	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	3.88e-06	0.000259	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—CAT—rheumatoid arthritis	3.69e-06	0.000247	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	3.16e-06	0.000211	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	3.08e-06	0.000206	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—POMC—rheumatoid arthritis	2.47e-06	0.000165	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.28e-06	0.000152	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—ALB—rheumatoid arthritis	2.25e-06	0.00015	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—NOS3—rheumatoid arthritis	2.15e-06	0.000144	CbGpPWpGaD
Ticagrelor—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.97e-06	0.000131	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.9e-06	0.000127	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.52e-06	0.000101	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.38e-06	9.25e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.32e-06	8.85e-05	CbGpPWpGaD
Ticagrelor—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.21e-06	8.09e-05	CbGpPWpGaD
